BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kimer N, Meldgaard M, Hamberg O, Kronborg TM, Lund AM, Møller HJ, Bendtsen F, Ytting H. The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial. PLoS One 2022;17:e0264278. [PMID: 35286322 DOI: 10.1371/journal.pone.0264278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Humphry N. Recent Findings in the Gut-Liver Axis and Associated Disease Therapy. EMJ Hepatol 2022. [DOI: 10.33590/emjhepatol/10154221] [Reference Citation Analysis]
2 Zafari N, Velayati M, Fahim M, Maftooh M, Pourali G, Khazaei M, Nassiri M, Hassanian SM, Ghayour-Mobarhan M, Ferns GA, Kiani MA, Avan A. Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective. Life Sci 2022;:120760. [PMID: 35787997 DOI: 10.1016/j.lfs.2022.120760] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]